Proteolytic conversion of hepatitis B virus e antigen precursor to end product occurs in a postendoplasmic reticulum compartment
暂无分享,去创建一个
[1] J. Ou,et al. Phosphorylation of hepatitis B virus precore and core proteins , 1991, Journal of virology.
[2] J. Rothman,et al. A coat subunit of Golgi-derived non-clathrin-coated vesicles with homology to the clathrin-coated vesicle coat protein β-adaptin , 1991, Nature.
[3] J. Ou,et al. Transport of hepatitis B virus precore protein into the nucleus after cleavage of its signal peptide , 1989, Journal of virology.
[4] A. S. Lee,et al. The rat 78,000 dalton glucose-regulated protein (GRP78) as a precursor for the rat steroidogenesis-activator polypeptide (SAP): the SAP coding sequence is homologous with the terminal end of GRP78. , 1989, Molecular endocrinology.
[5] T. Nakaki,et al. Enhanced transcription of the 78,000-dalton glucose-regulated protein (GRP78) gene and association of GRP78 with immunoglobulin light chains in a nonsecreting B-cell myeloma line (NS-1) , 1989, Molecular and cellular biology.
[6] J. Lippincott-Schwartz,et al. Rapid redistribution of Golgi proteins into the ER in cells treated with brefeldin A: Evidence for membrane cycling from Golgi to ER , 1989, Cell.
[7] H. Blum,et al. The molecular biology of hepatitis B virus. , 1989, Trends in genetics : TIG.
[8] W. Rutter,et al. A signal peptide encoded within the precore region of hepatitis B virus directs the secretion of a heterogeneous population of e antigens in Xenopus oocytes. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[9] L. Hendershot,et al. Identity of the immunoglobulin heavy-chain-binding protein with the 78,000-dalton glucose-regulated protein and the role of posttranslational modifications in its binding function , 1988, Molecular and cellular biology.
[10] W. Gerlich,et al. Formation of transmembraneous hepatitis B e-antigen by cotranslational in vitro processing of the viral precore protein. , 1988, Virology.
[11] W. Rutter,et al. Targeting of the hepatitis B virus precore protein to the endoplasmic reticulum membrane: after signal peptide cleavage translocation can be aborted and the product released into the cytoplasm , 1988, The Journal of cell biology.
[12] P. Galle,et al. Expression and replication of the hepatitis B virus genome under foreign promoter control. , 1987, Nucleic acids research.
[13] H. Will,et al. Expression of the hepatitis B virus core gene in vitro and in vivo , 1987, Journal of virology.
[14] H. Varmus,et al. The molecular biology of the hepatitis B viruses. , 1987, Annual review of biochemistry.
[15] Y. Misumi,et al. Novel blockade by brefeldin A of intracellular transport of secretory proteins in cultured rat hepatocytes. , 1986, The Journal of biological chemistry.
[16] A. Siddiqui,et al. Expression of hepatitis B viral core region in mammalian cells , 1986, Molecular and cellular biology.
[17] J. Kearney,et al. Posttranslational association of immunoglobulin heavy chain binding protein with nascent heavy chains in nonsecreting and secreting hybridomas , 1986, The Journal of cell biology.
[18] W. Rutter,et al. Hepatitis B virus gene function: the precore region targets the core antigen to cellular membranes and causes the secretion of the e antigen. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[19] R. Kelly. Pathways of protein secretion in eukaryotes. , 1985, Science.
[20] P. Vassalli,et al. Lectin-binding sites as markers of Golgi subcompartments: proximal-to- distal maturation of oligosaccharides , 1983, The Journal of cell biology.
[21] P Berg,et al. Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. , 1982, Journal of molecular and applied genetics.
[22] F. Tsuda,et al. Association of dane particles with e antigen in the serum of asymptomatic carriers of hepatitis B surface antigen. , 1976, Journal of immunology.
[23] J. Nielsen,et al. Incidence and meaning of the "e" determinant among hepatitis-B-antigen positive patients with acute and chronic liver diseases. Report from the Copenhagen Hepatitis Acuta Programme. , 1974, Lancet.